Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
embecta
MedTech
Embecta shutters insulin patch pump program amid restructuring
Despite winning an FDA green light three months ago for its first wearable insulin system, Embecta is now discontinuing its patch pump program.
Conor Hale
Nov 26, 2024 12:52pm
Embecta's insulin patch pump secures FDA nod in Type 2 diabetes
Sep 3, 2024 2:29pm
BD cuts 60 jobs at Irish site to ‘right-size’ manufacturing
Jul 5, 2023 11:25am
Embecta dives into Type 2 diabetes tech with Tidepool team-up
May 15, 2023 12:24pm
Embecta beats its own estimates in first 6 months of BD spinout
Dec 22, 2022 11:07am
Embecta to promote Intuity's push-button glucose reader
Nov 7, 2022 10:02am
